Business
Zero Candida Announces Corporate Changes
Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) (OTC: ZCTFF) an Israeli FemTech medical device start-up, wishes to advise that it has elected to adopt semi-annual financial reporting ("SAR") in reliance on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933").
About this update from Zero Candida Technologies Inc.
[{"type":"text","content":"VANCOUVER, BC, May 25, 2026 /PRNewswire/ -- Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) (OTC: ZCTFF) an Israeli FemTech medical device start-up, wishes to advise that it has elected to adopt semi-annual financial reporting ("SAR") in reliance on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933").","length":417,"tagName":"p"},{"type":"image","alt":"Zero Candida Logo","displaySize":"","headline":null,"caption":"Zero Candida Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/cnwgroup.com/6c3933861139510bab620273d40833d9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oYXzmMYxV9OfCxRqpZ49gg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNQ--/https://media.zenfs.com/en/cnwgroup.com/6c3933861139510bab620273d40833d9","width":400,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/qKBoGNMQJhz6axeraxtyIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MA--/https://media.zenfs.com/en/cnwgroup.com/6c3933861139510bab620273d40833d9","width":400,"height":400}}},{"type":"text","content":"Under the SAR framework, the Company will be exempt from filing interim financial reports and related Management's Discussion & Analysis ("MD&A") for its first and third quarters. Specifically:","length":215,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"the Company will not file interim financial reports or related MD&A for the first quarter (Q1) ending March 31, 2026, or the third quarter (Q3) ending September 30, 2026; and","length":178,"tagName":"p"}]},{"val":[{"type":"text","content":"the Company will continue to file audited annual financial statements within 120 days of December 31 and six-month interim financial reports within 60 days of June 30.","length":167,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":345,"olType":false},{"type":"text","content":"The Company confirms that it meets the eligibility criteria under CBO 51-933, including that it is a venture issuer with annual revenues of less than $10 million and is current in all required periodic and timely continuous disclosure filings.","length":243,"tagName":"p"},{"type":"text","content":"This news release is being filed pursuant to C...